Invictus MD Strategies EV/EBITDA
Qual é o EV/EBITDA de Invictus MD Strategies?
O EV/EBITDA de Invictus MD Strategies Corp. é N/A
Qual é a definição de EV/EBITDA?
EV/EBITDA é o valor da empresa dividido pelo lucro antes de juros, impostos, depreciação e amortização. É uma medida de quão cara é uma ação e é mais frequentemente válida para comparações entre empresas do que da relação entre preço e lucro. Ele mede o preço (na forma de valor da empresa) que um investidor paga em benefício do fluxo de caixa da empresa (na forma de EBITDA).
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV/EBITDA de empresas na Setor Health Care em OTC em comparação com Invictus MD Strategies
O que Invictus MD Strategies faz?
Invictus MD Strategies Corp. invests in, acquires, and develops synergistic businesses in the cannabis industry in Canada. The company operates through two segments, Sale of Cannabis and Fertilizers. It produces and sells medical cannabis; and plant fertilizers, nutrients, and other supplies for hydroponics, as well as operates medical clinics in Alberta. The company was incorporated in 2014 and is headquartered in Vancouver, Canada.
Empresas com ev/ebitda semelhantes a Invictus MD Strategies
- ADiTx Therapeutics tem EV/EBITDA de N/A
- Ultra Petroleum tem EV/EBITDA de N/A
- Ultra Petroleum tem EV/EBITDA de N/A
- ProShares Managed Futures Strategy tem EV/EBITDA de N/A
- Global Health Clinics Ltd tem EV/EBITDA de N/A
- EMCO tem EV/EBITDA de N/A
- Invictus MD Strategies tem EV/EBITDA de N/A
- Hardy Oil and Gas plc tem EV/EBITDA de N/A
- Tungsten West PLC tem EV/EBITDA de N/A
- Clenergen tem EV/EBITDA de N/A
- Royal BAM Groep NV tem EV/EBITDA de N/A
- Nutraplus India tem EV/EBITDA de N/A
- PhaseBio Pharmaceuticals tem EV/EBITDA de N/A